Patients living with cancer: The role of rehabilitation

Australian Family Physician

Volumn 39, Issue 11, 2010, Pages 844-846

  Gupta, Anupam Datta ^a   Lewis, Sue ^b   Shute, Russell ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Breast neoplasms; Neoplasms; Rehabilitation

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CASE REPORT; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MASTECTOMY; NEOPLASM; PAIN; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SURVIVOR;

ACTIVITIES OF DAILY LIVING; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MASTECTOMY; NEOPLASMS; PAIN; QUALITY OF LIFE; SURVIVORS;

EID: 78650184916     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. UDSMR Adult FIM Workshop - participant manual, version 5.0 (Australia). Buffalo, NY 14214: State University of New York Buffolo; 1999.
2. Konagaya M, Bernerd PA, Max SR. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology 1986;119:375-80.
3. Sun L, Trausch-Azar JS, Muglia LJ, et al. Glucocorticoid differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism. Proc Natl Acad Sci USA 2008;105:3339-44.
4. Batchelor TT, Taylor LP, Thaler HT, et al. Steroid myopathy in cancer patients. Neurology 1997;48:1234-8.
5. Dropcho EJ, Soong SJ. Steroid-induced weakness in patients with primary brain tumors. Neurology 1991;41:1235-9.
6. Ferrando AA, Stuart CA, Sheffield-Moore M, et al. Inactivity amplifies the catabolic response of skeletal muscle to cortisol. J Clin Endocrinol Metab 1999;64:3515-21.
7. Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 1985;76:234-42.
8. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology: cancer and treatment-related anaemia. Version 3, 2009. Available at www.nccn.org/professionals/physician_gls/f_giudelines.asp.
9. Nieboer P, Buijs C, Rodenhuis S, et al. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longituidinal study. J Clin Oncol 2005;23:8280-2.
10. Dy SM, Lorenz KA, Naeim A, et al. Evidence-based recommendations for cancer fatigue, anorexia, depression and dyspnoea. J Clin Oncol 2008;26:3886-95.
11. Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 2004;91:822-8.
12. Cheville AL, Troxel AB, Basford JR, et al. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol 2008;26:2621-9.